Cambed, Aepralyn Joy M.
HRN: 23-65-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/06/2023
09/12/2023
IVTT
500 Mg
Q8
Infectious Diarrhea (Intestinal Amoebiasis)
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes